The Practical Recommendations in Immuno and Molecular Oncology Meeting

is a unique opportunity to receive CME/CE credits while staying ahead of the latest advances in immuno and molecular oncology.

The Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months and features anticipated advances that you and your patients will likely see in the upcoming year.

Agenda

The 2020 agenda has been curated by our Co-Chairs and Steering Committee to ensure that it meets the educational needs of all our attendees, with an emphasis on the following areas:

Practical considerations of applying biomarkers and targeted therapy

Integration of immunotherapy, with a focus on novel management approaches

Patient selection, as well as timing and sequencing of therapy

Dealing with important trends, such as big data and defining value in cancer care

Faculty

An elite faculty is in the process of being assembled for the 2020 Annual PRIMO Meeting by our Steering Committee, led by our Co-Chairs Dr. Brahmer, Dr. Rugo, and Dr. Vose

Co-Chairs

Julie R. Brahmer, MD, MSc

Professor of Oncology
Director, Thoracic Oncology Program
Interim Director, Johns Hopkins
Kimmel Cancer Center at Bayview
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins School of Medicine
Baltimore, MD

Hope S. Rugo, MD, FASCO

Professor of Medicine
Director, Breast Oncology
and Clinical Trials Education
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, CA

Julie M. Vose, MD, MBA

Neumann M. and Mildred E. Harris Professor
Chief, Division of Oncology/Hematology
Professor of Medicine
University of Nebraska Medical Center
Omaha, NE

Exhibitors and Sponsors

The PRIMO Meeting offers a fantastic opportunity for industry to interact with leading multidisciplinary oncologists and stay up to date with the latest information regarding targeted and immunologic therapies.